NYSE: CRKComstock Resources Inc Stock
$23.84-0.29 (-1.2%)
Updated Dec 30, 2025
CRK Price
$23.84
Fair Value Price
N/A
Market Cap
$6.99B
52 Week Low
$14.65
52 Week High
$31.17
P/E
91.69x
P/B
2.96x
P/S
3.21x
PEG
1.29x
Dividend Yield
N/A
Revenue
$1.80B
Earnings
$56.56M
Gross Margin
55.9%
Operating Margin
11.93%
Profit Margin
3.7%
Debt to Equity
1.79
Operating Cash Flow
$942M
Beta
1.15
Next Earnings
Feb 17, 2026
Ex-Dividend
N/A
Next Dividend
N/A
CRK Overview
Comstock Resources, Inc. is a natural gas exploration and production company with operations in the Haynesville shale in North Louisiana and East Texas. The company was incorporated in 1919 and is headquartered in Frisco, TX.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CRK's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Oil and Gas
Industry Rating
F
CRK
Ranked#35 of 65
Ranked#35 of 65
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $213.07 | B | |
| $11.82 | B | |
| $0.88 | B |
Be the first to know about important CRK news, forecast changes, insider trades & much more!
CRK News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CRK scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CRK ($23.84) is trading above its intrinsic value of $8.42, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CRK is poor value based on its earnings relative to its share price (91.69x), compared to the US market average (44.23x)
P/E vs Market Valuation
CRK is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CRK due diligence checks available for Premium users.
Valuation
CRK price to earnings (PE)
For valuing profitable companies with steady earnings
Company
91.69x
Industry
15.65x
Market
44.23x
CRK is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CRK is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
CRK price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.96x
Industry
1.45x
CRK is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CRK price to earnings growth (PEG)
For valuing profitable companies with growth potential
CRK is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CRK's financial health
Profit margin
Revenue
$449.9M
Net Income
$111.1M
Profit Margin
24.7%
CRK's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CRK's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$6.8B
Liabilities
$4.2B
Debt to equity
1.79
CRK's short-term liabilities ($649.81M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CRK's long-term liabilities ($3.57B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CRK's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CRK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$153.1M
Investing
-$324.0M
Financing
$164.2M
CRK's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CRK vs Oil and Gas Stocks
Comstock Resources Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.